KR20130131117A - Method for measuring analytes in blood samples using electrochemical biosensor and a portable analyzer - Google Patents
Method for measuring analytes in blood samples using electrochemical biosensor and a portable analyzer Download PDFInfo
- Publication number
- KR20130131117A KR20130131117A KR1020120054932A KR20120054932A KR20130131117A KR 20130131117 A KR20130131117 A KR 20130131117A KR 1020120054932 A KR1020120054932 A KR 1020120054932A KR 20120054932 A KR20120054932 A KR 20120054932A KR 20130131117 A KR20130131117 A KR 20130131117A
- Authority
- KR
- South Korea
- Prior art keywords
- blood
- voltage
- hematocrit
- concentration
- measuring
- Prior art date
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Abstract
A method for measuring the concentration of an analyte in a blood sample according to an embodiment of the present invention includes a cell containing a blood sample and an electrochemical biosensor having a working electrode and an auxiliary electrode in the cell. Applying a constant voltage after cold, applying a circulating voltage continuously after applying the constant voltage, linearly combining at least two current values measured corresponding to the constant voltage and the circulating voltage, and Obtaining characteristic information, and correcting the influence of the characteristic information of the blood.
According to this structure, the accuracy of the biosensor can be improved by correcting the influence of hematocrit in the blood by applying a circulating voltage.
Description
The present invention relates to an electrochemical biosensor, a portable measuring instrument and a method for measuring the concentration of an analyte in a blood sample using the same, and more particularly, a portable meter for electrochemically analyzing a blood sample. Electrochemical biosensors and portable instruments that improve the measurement accuracy by artificially correcting the effects of hematocrit on the measurement of the analyte concentration in the results obtained by applying a combination of cyclic voltammetry And it relates to a method for measuring the concentration of the analyte in blood samples using them.
Methods of measuring various metabolites or protein substances in the blood using electrochemical biosensors are known.
In particular, electrochemical biosensors are used as an essential tool for managing diabetes because they can measure blood glucose with portable instruments. For example, electrochemical biosensors, which are widely used in recent years, are configured to easily inhale a small amount of microliter blood sample into a capillary sample cell, so that blood sugar can be conveniently measured anywhere.
In spite of this convenience, electrochemical biosensors have a problem of inaccuracy due to various interferences (eg, ascorbic acid, uric acid, acetaminophen, etc.) that may exist in blood samples or the effect of different red blood cell volume (hematocrit) for each individual. have.
In order to solve this problem, many studies have been continued to minimize the effects of hematocrit by redesigning the structure of the biosensor or analyzing signals obtained from the biosensor.
U.S. Patent No. 5,708,247 discloses a biosensor that filters red blood cells using a fine mesh made of polyester. However, these biosensors require a large amount of blood for measurement and have a long measurement time.
US Patent No. 5,264,103 discloses a method of correcting the effects of hematocrit based on the time difference of electrical characteristics measured when blood enters each pair of electrodes using a biosensor having two pairs of electrodes on one plane. .
US Patent No. 7,258,769 discloses a method of correcting the effects of hematocrit by measuring the time that blood flows from a flow sensing electrode into a sample cell after a blood sample comes into contact with a large working electrode and an auxiliary electrode.
However, these methods have a problem that the accuracy of correction is lowered because the inflow time varies depending on the dry state of the biosensor reagent or the influence of external humidity.
US Patent Publication No. 2010-0276303, US Patent Publication No. 2010-0243476, and US Patent Publication No. 2007-0062822 are based on the fact that the amount of current generated when water is oxidized in a sample varies according to hematocrit. A method for correcting the effects of hematocrit has been disclosed.
This method requires a separate electrode to measure the amount of current generated when the water is oxidized, and the electrode must be made of precious metals such as palladium (Pd) or platinum (Pt). There is a problem that it is more expensive than the electrode.
In US Pat. No. 3,648,160, US Pat. No. 4,699,887, US Pat. No. 3,922,598, US Pat. 4,068,169, US Pat. In the US Patent 7,407,811, US Patent 7,390,667, US Patent 7,338,639, etc., a method for measuring glucose by correcting the effect of hematocrit has been disclosed.
However, in this method, the electrical signal measured from the working electrode and the auxiliary electrode by applying the alternating voltage simultaneously contains the electrical signal due to glucose and the electrical signal related to the hematocrit in a complicated manner, and the hematocrit correction algorithm is complicated. There is also a problem that is not easy to secure reliability.
US Patent No. 6,287,451 discloses a method for correcting the effect of hematocrit by measuring the resistance of a sample using a biosensor having a separate resistance measurement electrode.
US Patent Publication No. 2011-0139634 discloses a method of calibrating hematocrit by measuring the conductivity of blood by applying alternating current to a biosensor having a separate, independent pair of electrodes. These methods measure hematocrit separately and are highly reliable, but the biosensor fabrication process can be complicated and the amount of sample required can be increased.
The present invention has been made to solve such a problem, and an object of the present invention is a portable meter that electrochemically analyzes blood samples without modifying existing biosensors. Electrochemical biosensors, portable instruments, and blood using them that improve the accuracy of measurement by artificial intelligence algorithms that compensate for the effects of hematocrit on the measurement of the analyte concentration in the results obtained by a combination of cyclic voltammetry. It is to provide a method for measuring the concentration of the analyte in the sample.
Method for measuring the concentration of the analyte in the blood sample according to an embodiment of the present invention,
Applying a constant voltage after the blood sample is filled to the cell for the cell containing the blood sample, and the electrochemical biosensor having the working electrode and the auxiliary electrode in the cell; Obtaining the characteristic information of blood by linearly combining at least two current values measured corresponding to the predetermined voltage and the circulating voltage, and correcting the influence of the characteristic information of blood. Characterized in that it comprises a.
According to one embodiment of the invention, for a small amount of blood sample, it is possible to use the existing biosensor without incurring complicated manufacturing process or cost, and measured by applying a circulating voltage continuously after applying a constant voltage to the existing biosensor By combining the current values in a linear combination, it is possible to obtain the characteristic information in the blood, for example, hematocrit, simply and not easily, thereby increasing the measurement accuracy of the concentration of a specific substance, especially glucose, in the blood sample.
In addition, according to one embodiment of the present invention, using a method for measuring the concentration of a specific substance in the blood according to an embodiment of the present invention for a small amount of blood sample, without using a complicated manufacturing process or costs for existing biosensors It can be used, and only the application of the voltage and the circulating voltage can provide a portable instrument that is practical and economical and can increase the accuracy of the measurement of the concentration of a specific substance in the blood sample.
1 is a conceptual block diagram of a portable instrument connected to a face-to-face biosensor according to an embodiment of the present invention.
2 is a conceptual block diagram of a portable instrument connected to a planar biosensor according to an embodiment of the present invention.
Figure 3 is a flow chart for explaining a method for measuring the concentration of a specific substance in the blood according to an embodiment of the present invention.
4 is a flowchart illustrating a blood glucose measurement method according to an embodiment of the present invention.
FIG. 5A is a graph illustrating a change in time-applied voltage (applied voltage vs. time) to explain a blood glucose measurement method according to a comparative example.
FIG. 5B is a graph showing a current value for the glucose standard sample at the end point of time applied voltage of FIG. 5A.
FIG. 6A is a graph illustrating the application of a cyclic voltage at the end point of time applied voltage of FIG. 5A.
FIG. 6B is a graph in which the time-dependent voltage is changed in FIG. 6A.
FIG. 6C is an enlarged view of the current value profile for the first cyclic voltage of FIG. 6A.
FIG. 6D is a graph illustrating a relationship between a current value and an applied voltage with respect to the second cyclic voltage of FIG. 6C.
7 is a graph showing a measurement error of the method for measuring the concentration of a specific substance in the blood according to an embodiment of the present invention.
8 is a graph showing a measurement error of the method for measuring the concentration of a specific substance in the blood according to another embodiment of the present invention.
Hereinafter, a method for measuring the concentration of a specific substance in blood and a portable measuring device using the same according to a preferred embodiment of the present invention will be described in detail with reference to the accompanying drawings.
In the present specification, it is described as a preferred embodiment to correct the occurrence of the measurement error by the hematocrit at the time of blood glucose measurement, but, like the glucose test, by introducing a specific enzyme, various metabolites, for example, cholesterol, lactate, creatinine Concentrations of organic or inorganic substances, such as hydrogen peroxide, alcohols, amino acids, and gurutamate, can also be corrected in the same way.
Therefore, the present invention can be used for quantification of various metabolites by varying the type of enzyme included in the sample layer composition.
For example, glucose oxidase (GOx), glucose dehydrogenase (GDH), glutamate oxidase glutamate dehydrogenase, cholesterol oxidase, cholesterol esterase, Lactate oxidase, ascorbic oxidase, alcohol oxidase, alcohol dehydrogenase, bilirubin oxidase and the like can be used to quantify glucose, glutamate, cholesterol, lactate, ascorbic acid, alcohol, bilirubin and the like. .
In a portable measuring device according to an embodiment of the present invention, a working electrode and an auxiliary electrode are provided to face each other on different planes, and a face type electrochemical coated with a reagent composition including an enzyme and an electron transfer medium according to a material on the working electrode. Biosensors can be applied.
In addition, the portable measuring instrument according to an embodiment of the present invention, the working electrode and the auxiliary electrode is provided on one plane, the planar electrochemical bio-coated with the reagent composition including the enzyme and the electron transfer medium according to the material on the working electrode Sensors can be applied.
First, a method for measuring the concentration of a specific substance in blood and a portable measuring device using the same will be described with reference to FIGS. 1 to 4.
1 and 2, the
Referring to FIG. 1, the
The working
The
Of course, such a face-type biosensor, Republic of Korea Patent Application 10-2003-0036804, 10-2005-0010720, 10-2007-0020447, 10-2007-0021086, 10-2007-0025106, 10-2007- 0030346 and EK Bauman et al., Analytical Chemistry, vol 37, p 1378, 1965 and KB Oldham in "Microelectrodes: Theory and Applications," Kluwer Academic Publishers, 1991.
On the other hand, the face-
The face-
Reagent composition for blood glucose measurement coated on the
Of course, as shown in FIG. 2, the
The
The working electrode 103 'and the auxiliary electrode 104' have an area of about 1.05 by an insulating film 109 'coated with a sample layer 108' disposed under the pressure-sensitive separator 107 '. The pressure-adhesive separator 107 'may be provided with a
The
As described above, even when the
According to the portable measuring device (100, 100 ') according to an embodiment of the present invention, the concentration of blood substances, hematocrit, temperature and other received current value obtained by applying a voltage to the existing electrochemical biosensors (110, 110') By correcting the effects of interfering substances, the concentration of specific substances in the blood can be accurately corrected.
Hereinafter, a method of measuring the concentration of a specific substance (glucose) in the blood used in a portable measuring instrument according to an embodiment of the present invention will be described with reference to FIGS. 3 and 4.
Referring to Figure 3, the method for measuring the concentration of a specific substance in the blood used in the portable measuring instrument according to an embodiment of the present invention to prepare a sample (S110), for example, portable
The cyclic voltage may be a triangular waveform with a simple operation.
The
In the method for measuring the concentration of a specific substance in the blood according to an embodiment of the present invention, the specific substance may be glucose.
Referring to FIG. 4, a blood glucose measurement method according to an embodiment of the present invention is applied to a blood sample inhaled by a biosensor continuously applying a circulating voltage following a predetermined voltage (S210), and according to the application of the circulating voltage. Obtaining a current value (S220), and obtaining a correlation coefficient between the current value and the hematocrit and blood glucose in the blood (S230), find at least one or more variables providing information of the hematocrit in the blood (S240), An equation for hematocrit or glucose is derived through an intelligent method or statistical regression analysis (S250), and the effect of the hematocrit is corrected using this equation (S260) to obtain an improved final blood glucose value (S270). ).
Hereinafter, in the method for measuring the concentration of a specific substance in blood according to an embodiment of the present invention with reference to FIGS. 5A to 7, it is used to increase the concentration of a specific substance in blood, in particular blood glucose measurement accuracy. The method for correcting the effect of the generated hematocrit is described in detail.
First, a conventional blood glucose measurement method using the face-
FIG. 5A is a graph illustrating a change in time-applied voltage (applied voltage vs. time) to explain a blood glucose measurement method according to a comparative example.
FIG. 5B is a graph showing a current value for the glucose standard sample at the end point of time applied voltage of FIG. 5A.
<Comparative Example>
In general, the conventional blood glucose measurement method measures a current value generated by applying a constant voltage to a conventional flat or large surface type electrochemical biosensor through a portable measuring instrument and applying an oxidation potential of a reduced electron transfer medium at a working electrode. The concentration of was determined.
According to a comparative example, the sample of the face-
The sample is a glucose standard solution, and the glucose standard solution is blood prepared by adjusting blood extracted from a vein to 20% to 60% of hematocrit and having various glucose concentrations using a glucose analyzer, that is, 2300 Stat Plus of YSI. In this regard, standard blood samples of 80, 150, 300 and 500 mg / dL concentrations were measured five times each.
By using the glucose standard solution as described above, it is possible to know the difference between the given glucose concentration and the glucose concentration using the large-area
As shown in FIG. 5B, a 20% hematocrit blood sample has a relatively high current value when compared to a 42% blood sample, whereas a
In other words, it can be seen that the current value changes according to the amount of hematocrit in the blood and the concentration of blood glucose also varies.
More specifically, a sample with 20% hematocrit has a 10 to 30% higher measurement deviation than a sample with 42%, and a sample with a 60% hematocrit is -10 to -20% lower than a sample with 42% It can be seen that it causes an error.
On the contrary, according to the method for measuring the concentration of a specific substance in the blood according to an embodiment of the present invention, the measurement error according to the hematocrit can be corrected compared to the method for measuring the concentration of the specific substance in the blood according to the comparative example.
According to the experimental example of the blood glucose measurement method according to an embodiment of the present invention to be described later, it will be described with reference to Figure 6a to Figure 7 that can reduce the measurement error compared to the comparative example by correcting the measurement error according to the hematocrit.
FIG. 6A is a graph illustrating the application of the circulating voltage at the end point of the time applied voltage of FIG. 5A, FIG. 6B is a graph showing the change of the time applied voltage in FIG. 6A, and FIG. 6C is a current value for the first cyclic voltage of FIG. 6A. Figure 6d is an enlarged view of the profile, Figure 6d is a graph showing the relationship between the current value and the applied voltage for the second circulating voltage of Figure 6c, Figure 7 is a method of measuring the concentration of a specific substance in the blood according to an embodiment of the present invention It is a graph showing measurement error.
<Experimental Example 1>
In the blood glucose measurement method according to an embodiment of the present invention, as shown in FIG. 6A, similarly to the comparative example, when the sample covers the working
The current value obtained for this voltage application was used to calculate hematocrit using multiple regression analysis represented by the following equation (1).
Hematocrit = β 0 + β 1 X 1 + β 2 X 2 +... + β 8 X 8 + β 9 X 9 +. + ε h (1)
Wherein β 0 is a constant β 1 , β 2 ,. β 8 and β 9 are independent variables X 1 , X 2 ,.. Is the coefficient of X 8 and X 9 , and ε h is the error term.
Table 1 shows 11 independent variables that correlate well with the dependent variable hematocrit, the number of which is not limited to the 11 described here.
Where i x is the current value in x seconds.
6C and 6D illustrate, by way of example, independent variables with high correlation.
6C and 6D, the relationship between the current value profile for the initial cyclic voltage, the current value for the second cyclic voltage, and the applied voltage as shown in FIG. 6A shows that the hematocrit is 20% and the concentration of glucose is 150 mg. For standard solutions of / dL, current value at 125 mV when scanning from low front to high front, i 5.1025 (= 16.58 μA) and current at 125 mV when scanning from high front to low forward i 5.1525 (= 9.56 μA) is 7.02 μA (= 16.58 μA-9.56 μA).
For standard samples with 40% hematocrit, the difference is 6.54 μA (= 14.48 μA-7.94 μA), and for standard samples with 60% hematocrit, the difference is 5.77 μA (= 12.92 μA-7.15 μA).
Therefore, the larger the difference in hematocrit, the larger i 5.1025 and i 5.1525 are useful variables that correlate with hematocrit.
Regression analysis of these variables on hematocrit leads to the following equation (1).
Hematocrit = -3213-31.9 × i 5 .2025 + 63.9 × i 5 .2525 + 251 × (i 5 .2025 / i 5 .2525 ) + 143 × i 5 .1275-56.0 × i 5 .1775-17.4 × ( i 5 .1275 / i 5 .1775) + 17.4 ×
The final blood glucose value can be calculated by calculating the hematocrit from Equation (2) above and arithmetic through the current value to determine how much the value affects the measurement of the blood glucose value.
As described above, the method of correcting the influence on the measurement error caused by the hematocrit shows a measurement error as shown in FIG. 7.
As shown in Figure 7, it can be seen that the blood glucose values measured using a portable measuring instrument using a blood sugar measuring method according to an embodiment of the present invention is arranged around the
120 face-to-face electrochemical biosensors were repeatedly measured using a portable measuring instrument according to an embodiment of the present invention.
As shown in Table 2, it can be seen that the error range is within 10% for all 120 electrochemical biosensors.
As a result, it can be seen that the blood glucose measurement method according to an embodiment of the present invention can increase the accuracy of the blood glucose measurement value by correcting the effect of hematocrit by applying a circulating voltage at the end point of the applied voltage for a long time.
<Experimental Example 2>
Although Experimental Example 1 suggests a method for increasing the accuracy of blood glucose values based on hematocrit in blood samples, the measured current value is not only hematocrit, but also an electrochemically oxidized or reduced interference material present in the sample and the blood sample. Since it is affected by the physical properties of the other samples, the blood glucose value was directly calculated using the following equation without going through the process of deriving the hematocrit as shown in equations (1) and (2).
glucose = γ0 + γ1X1 + γ2X2 +... + gamma 8X8 + gamma 9X9 +... + εg (3)
Where γ0 is a constant, γ1, γ2,... γ8 and γ9 are independent variables X1, X2,... Is the coefficient of X8 and X9, and εg is the error term.
In addition, in order to increase the reliability of the correction equation, a plurality of regression equations were derived by combining independent variables, and the average of those equations was calculated to calculate blood glucose values, and the results are shown in FIG. 8.
8 is a graph showing a measurement error of the method for measuring the concentration of a specific substance in the blood according to another embodiment of the present invention.
As shown in Figure 8, it can be seen that the blood glucose value measured using a portable measuring instrument using a blood glucose measurement method according to another embodiment of the present invention is arranged around the
As a result, the blood glucose measurement method according to an embodiment of the present invention is applied to the electrochemically oxidized or reduced interference materials and other samples present in the blood sample and the temperature of the sample by applying a circulating voltage at the end of the time-applied voltage It can be seen that the accuracy of the blood glucose measurement can be improved by correcting the influence of physical properties.
As shown in Fig. 6B, better hematocrit information can be extracted by changing the time-applied voltage portion or by changing the range and period of the cyclic voltage portion.
Although the blood glucose measurement method according to the exemplary embodiment of the present invention is applied to a large-area biosensor, the flat biosensor is not excluded and detailed description thereof is omitted since the same result was obtained for the flat biosensor.
Claims (12)
The characteristic information of the blood is hematocrit, and the specific substance is a method of measuring the concentration of the analyte in the blood sample which is blood sugar.
The characteristic information of the blood are analytes that cause redox currents other than redox currents generated by the activity of enzymes and electron transfer mediators. The specific analytes are glucose, lactate, cholesterol, A method for measuring the concentration of analyte in a blood sample which is one of creatine, creatinine, phenylketone and ketone.
The blood characteristic information is a method for measuring the concentration of an analyte in a blood sample obtained from a current value or a ratio of these current values at the time when the application direction of the circulating voltage changes.
The blood characteristic information is a method for measuring the concentration of analyte in a blood sample obtained from the current value of the intermediate voltage of the circulation voltage or the ratio of these current values.
The blood characteristic information is a method for measuring the concentration of the analyte in the blood sample obtained from the sum of the current values for the circulating voltage.
The constant voltage is a constant voltage, and the circulating voltage is made by a linear scan method, and the blood sample is corrected by extracting at least one characteristic information of the blood by changing the range and cycle of the constant voltage and the circulating voltage. Method for measuring the concentration of analyte in the middle.
The hematocrit is calculated by using the current value according to the application of the cyclic voltage calculated according to Equation (1),
Hematocrit = + ε h (1)
here Is the linear coupling coefficient obtained from the regression analysis. Is a current value or ratio of current values at various points measured while an applied voltage is applied, and ε h is an error term.
The amount of the interfering substance is calculated using the current value according to the application of the cyclic voltage calculated according to equation (1),
Hematocrit = + ε h (1)
here Is the linear coupling coefficient obtained from the regression analysis. Is a current value or ratio of current values at various points measured while an applied voltage is applied, and ε h is an error term.
The blood sugar is calculated using the current value according to the application of the cyclic voltage calculated according to equation (3),
glucose = + εg (3)
here Where is the linear regression coefficient and εg is the error term.
The constant voltage applying unit, the circulating voltage applying unit, and the constant voltage applying unit for applying a constant voltage according to the method for measuring the concentration of a specific substance in the blood according to any one of claims 1 to 10 for the electrochemical biosensor When a constant voltage is applied to the electrochemical biosensor, the current value according to the redox reaction of the enzyme and the electron transfer medium of the electrochemical biosensor and the cyclic voltage applied by the cyclic voltage applying unit are analyzed. Portable measuring instrument including a correction processing unit for correcting the influence of the characteristic information of the blood through.
The correction processing unit
Correcting the influence caused by the hematocrit,
Reading current values resulting from applying the linear scan cyclic voltage;
Obtaining a correlation coefficient between the current values and the hematocrit in the blood;
Obtaining at least one variable that provides information of hematocrit in the blood using the correlation coefficient;
Regressing the variable to derive an equation for hematocrit;
Subtracting a value that affects the current values by the hematocrit from the current value,
Portable measuring instrument comprising a concentration measurement program of a specific substance in the blood comprising the step of obtaining the concentration of the substance in the blood by the current value.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120054932A KR101357134B1 (en) | 2012-05-23 | 2012-05-23 | Method for Measuring Analytes in Blood Samples Using Electrochemical Biosensor and a Portable Analyzer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120054932A KR101357134B1 (en) | 2012-05-23 | 2012-05-23 | Method for Measuring Analytes in Blood Samples Using Electrochemical Biosensor and a Portable Analyzer |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130131117A true KR20130131117A (en) | 2013-12-03 |
KR101357134B1 KR101357134B1 (en) | 2014-02-05 |
Family
ID=49980481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120054932A KR101357134B1 (en) | 2012-05-23 | 2012-05-23 | Method for Measuring Analytes in Blood Samples Using Electrochemical Biosensor and a Portable Analyzer |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101357134B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160007204A (en) * | 2014-07-11 | 2016-01-20 | 최강 | The Biosensor |
EP2998731A1 (en) | 2014-09-17 | 2016-03-23 | i-Sens, Inc. | Apparatus and method for measuring concentration of an analyte in whole blood samples |
EP3447490A1 (en) * | 2017-08-25 | 2019-02-27 | Koninklijke Philips N.V. | Analyser for fluid sample analysis |
WO2020013361A1 (en) * | 2018-07-11 | 2020-01-16 | 주식회사 아이센스 | Method for measuring concentration of biometric measurement object by using artificial intelligence deep learning |
KR20210140853A (en) | 2020-05-14 | 2021-11-23 | 신한대학교 산학협력단 | Apparatus for Blood Collection Confirmation and Driving Method Thereof |
CN115078508A (en) * | 2022-06-21 | 2022-09-20 | 爱森斯(江苏)生物科技有限公司 | Electrochemical biosensor and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101597943B1 (en) * | 2015-08-17 | 2016-02-25 | 휴먼플러스(주) | Apparatus for simultaneous measuring of glucose and hematocrit |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1751533A2 (en) * | 2004-05-14 | 2007-02-14 | Bayer Healthcare, LLC | Voltammetric systems for assaying biological analytes |
KR100698961B1 (en) | 2005-02-04 | 2007-03-26 | 주식회사 아이센스 | Electrochemical Biosensor |
US8404100B2 (en) * | 2005-09-30 | 2013-03-26 | Bayer Healthcare Llc | Gated voltammetry |
-
2012
- 2012-05-23 KR KR1020120054932A patent/KR101357134B1/en active IP Right Grant
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160007204A (en) * | 2014-07-11 | 2016-01-20 | 최강 | The Biosensor |
US10690619B2 (en) | 2014-09-17 | 2020-06-23 | I-Sens, Inc. | Apparatus and method for measuring concentration of an analyte in whole blood samples |
KR20160032974A (en) * | 2014-09-17 | 2016-03-25 | 주식회사 아이센스 | Apparatus and Method for measuring concentration of Whole Blood Samples Using the same |
CN105738430A (en) * | 2014-09-17 | 2016-07-06 | 爱-森新株式会社 | Apparatus and method for measuring concentration of an analyte in whole blood samples |
CN105738430B (en) * | 2014-09-17 | 2019-02-22 | 爱-森新株式会社 | The concentration detection method and detection device of substance to be analyzed in biological sample |
EP2998731A1 (en) | 2014-09-17 | 2016-03-23 | i-Sens, Inc. | Apparatus and method for measuring concentration of an analyte in whole blood samples |
US11378540B2 (en) | 2014-09-17 | 2022-07-05 | I-Sens, Inc. | Apparatus and method for measuring concentration of an analyte in bio-samples |
EP3447490A1 (en) * | 2017-08-25 | 2019-02-27 | Koninklijke Philips N.V. | Analyser for fluid sample analysis |
WO2019038427A1 (en) | 2017-08-25 | 2019-02-28 | Koninklijke Philips N.V. | Analyser for fluid sample analysis |
WO2020013361A1 (en) * | 2018-07-11 | 2020-01-16 | 주식회사 아이센스 | Method for measuring concentration of biometric measurement object by using artificial intelligence deep learning |
KR20200006695A (en) * | 2018-07-11 | 2020-01-21 | 주식회사 아이센스 | Artificial Neural Network Model-Based Methods for Analyte Analysis |
KR20210140853A (en) | 2020-05-14 | 2021-11-23 | 신한대학교 산학협력단 | Apparatus for Blood Collection Confirmation and Driving Method Thereof |
CN115078508A (en) * | 2022-06-21 | 2022-09-20 | 爱森斯(江苏)生物科技有限公司 | Electrochemical biosensor and preparation method thereof |
CN115078508B (en) * | 2022-06-21 | 2024-01-19 | 爱森斯(江苏)生物科技有限公司 | Electrochemical biosensor and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101357134B1 (en) | 2014-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6522067B2 (en) | System, apparatus and method for improving biosensor accuracy using fill time | |
EP2193367B1 (en) | Method for correcting erroneous results of measurement in biosensors and apparatus using the same | |
KR101357134B1 (en) | Method for Measuring Analytes in Blood Samples Using Electrochemical Biosensor and a Portable Analyzer | |
JP4988059B2 (en) | Method and apparatus for rapid electrochemical analysis | |
US8414759B2 (en) | Analyte determination methods and devices | |
JP5837613B2 (en) | High accuracy analyte measurement system and method | |
AU2004268222B2 (en) | Method and apparatus for assay of electrochemical properties | |
KR101847369B1 (en) | Systems and methods for improved stability of electrochemical sensors | |
EP2577302B1 (en) | Slope-based compensation method including secondary output signals | |
CN104535631A (en) | Electrochemical measurement method | |
JP6403653B2 (en) | High accuracy analyte measurement system and method | |
US20170038331A1 (en) | System and method for compensating sample-related measurements based on polarization effects of test strips | |
JP6609001B2 (en) | High accuracy analyte measurement system and method | |
JP2017096977A (en) | System and method for accurately measuring analyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20161222 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20171204 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20181211 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20191210 Year of fee payment: 7 |